Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Jeffrey Montgomery

Concepts (424)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urinary Bladder Neoplasms
48
2023
173
9.510
 Why?
Cystectomy
30
2023
51
6.490
 Why?
Prostatic Neoplasms
40
2023
415
4.930
 Why?
Kidney Neoplasms
22
2018
196
2.890
 Why?
Carcinoma, Transitional Cell
13
2023
54
2.860
 Why?
Prostatectomy
21
2022
87
2.300
 Why?
Nephrectomy
19
2016
93
2.120
 Why?
Urinary Diversion
6
2021
44
1.750
 Why?
Lymph Node Excision
6
2018
140
1.730
 Why?
Laparoscopy
13
2014
188
1.610
 Why?
Quality of Life
12
2023
922
1.500
 Why?
Prostate
13
2023
117
1.410
 Why?
Aged
73
2021
10054
1.240
 Why?
Male
111
2023
27334
1.170
 Why?
Humans
140
2023
54284
1.120
 Why?
Middle Aged
80
2023
13088
1.110
 Why?
Robotics
8
2015
45
1.020
 Why?
Postoperative Complications
15
2021
1033
0.980
 Why?
Neoplasm Staging
22
2023
806
0.970
 Why?
Carcinoma, Renal Cell
10
2016
120
0.950
 Why?
Retrospective Studies
50
2023
6432
0.910
 Why?
Ureter
3
2016
38
0.870
 Why?
Exercise Therapy
1
2023
123
0.860
 Why?
Exercise
2
2023
552
0.840
 Why?
Hernia
2
2020
6
0.830
 Why?
Neoadjuvant Therapy
10
2023
125
0.760
 Why?
Herniorrhaphy
1
2020
26
0.750
 Why?
Intestine, Small
2
2020
123
0.750
 Why?
BCG Vaccine
5
2023
16
0.740
 Why?
Physical Fitness
1
2020
69
0.740
 Why?
Intestinal Obstruction
1
2020
37
0.730
 Why?
Neoplasm Recurrence, Local
14
2023
644
0.720
 Why?
Patient Readmission
6
2021
242
0.710
 Why?
Penile Neoplasms
2
2017
43
0.710
 Why?
Treatment Outcome
29
2023
5604
0.680
 Why?
Watchful Waiting
7
2019
29
0.680
 Why?
Ureteral Neoplasms
2
2018
12
0.650
 Why?
Biopsy
17
2023
692
0.630
 Why?
Aged, 80 and over
24
2021
3431
0.610
 Why?
Neoplasm Invasiveness
13
2023
295
0.580
 Why?
Urinary Bladder
7
2018
83
0.580
 Why?
Convalescence
1
2016
8
0.580
 Why?
Magnetic Resonance Imaging
10
2023
1604
0.580
 Why?
Female
56
2021
28441
0.550
 Why?
Testicular Neoplasms
3
2018
47
0.540
 Why?
Urothelium
4
2018
23
0.520
 Why?
Urologic Neoplasms
3
2019
17
0.490
 Why?
Ileum
1
2014
102
0.490
 Why?
Choline
3
2019
63
0.490
 Why?
Neoplasm Grading
13
2020
131
0.480
 Why?
Medical Oncology
4
2021
102
0.480
 Why?
Image-Guided Biopsy
5
2023
35
0.470
 Why?
Carcinoma in Situ
3
2020
74
0.460
 Why?
Prospective Studies
15
2023
2604
0.440
 Why?
Needles
3
2021
30
0.430
 Why?
Quality Indicators, Health Care
1
2013
99
0.430
 Why?
Urologic Surgical Procedures
3
2016
28
0.420
 Why?
Testicular Diseases
1
2011
4
0.400
 Why?
Biopsy, Needle
5
2021
195
0.400
 Why?
Chemotherapy, Adjuvant
6
2020
119
0.390
 Why?
Survival Rate
9
2021
951
0.390
 Why?
Antineoplastic Agents
3
2021
1300
0.390
 Why?
Urogenital Neoplasms
1
2010
9
0.380
 Why?
Tumor Burden
6
2016
142
0.380
 Why?
Prostate-Specific Antigen
7
2021
55
0.380
 Why?
Risk Assessment
10
2019
1361
0.380
 Why?
Muscle Neoplasms
1
2010
21
0.370
 Why?
Disease Progression
7
2020
913
0.360
 Why?
Carcinoma, Squamous Cell
3
2018
384
0.360
 Why?
Administration, Intravesical
6
2023
16
0.360
 Why?
Fluorine Radioisotopes
2
2019
25
0.360
 Why?
Retroperitoneal Space
5
2016
24
0.350
 Why?
Self Report
1
2010
204
0.350
 Why?
Lymphatic Metastasis
3
2020
256
0.350
 Why?
Psoas Muscles
2
2021
2
0.350
 Why?
Organ Sparing Treatments
4
2018
54
0.340
 Why?
Telomerase
2
2019
30
0.330
 Why?
Registries
3
2021
553
0.320
 Why?
Patient Selection
5
2019
286
0.320
 Why?
Magnetic Resonance Imaging, Interventional
3
2023
4
0.310
 Why?
Seat Belts
2
2017
21
0.310
 Why?
Urinary Catheterization
1
2007
25
0.310
 Why?
Urethral Stricture
1
2007
21
0.310
 Why?
Child Restraint Systems
2
2017
26
0.310
 Why?
Adult
25
2021
14207
0.300
 Why?
Neoplasms, Germ Cell and Embryonal
2
2018
17
0.300
 Why?
Positron-Emission Tomography
2
2019
322
0.300
 Why?
Primary Health Care
1
2011
401
0.290
 Why?
Time Factors
13
2020
3213
0.280
 Why?
Cohort Studies
8
2021
1543
0.280
 Why?
Length of Stay
6
2020
683
0.280
 Why?
Guideline Adherence
3
2017
148
0.280
 Why?
Tomography, X-Ray Computed
3
2021
1213
0.280
 Why?
Pain Measurement
2
2017
246
0.270
 Why?
Patient Discharge
3
2017
353
0.270
 Why?
Health Status
2
2015
368
0.260
 Why?
Bandages
1
2005
22
0.260
 Why?
Patient Participation
2
2016
70
0.260
 Why?
Urinary Incontinence
2
2017
40
0.260
 Why?
Carcinoma
2
2018
153
0.250
 Why?
Kidney
4
2014
820
0.250
 Why?
Surgical Wound Infection
1
2005
126
0.250
 Why?
Neurilemmoma
1
2004
28
0.250
 Why?
Multivariate Analysis
8
2016
643
0.240
 Why?
Quality Improvement
3
2016
245
0.240
 Why?
Adenocarcinoma
3
2016
428
0.240
 Why?
Age Factors
7
2021
1198
0.240
 Why?
Venous Thrombosis
1
2005
102
0.240
 Why?
Decision Making
2
2016
290
0.230
 Why?
Clinical Competence
3
2016
446
0.220
 Why?
Practice Guidelines as Topic
2
2018
492
0.220
 Why?
Urethra
3
2014
80
0.220
 Why?
Prognosis
9
2021
2118
0.210
 Why?
DNA, Neoplasm
2
2018
171
0.210
 Why?
Feasibility Studies
2
2020
398
0.210
 Why?
United States
12
2020
5217
0.200
 Why?
Vital Statistics
1
2021
3
0.200
 Why?
Mandatory Reporting
1
2021
13
0.200
 Why?
Death Certificates
1
2021
17
0.200
 Why?
Birth Certificates
1
2021
20
0.200
 Why?
Cell Transdifferentiation
1
2021
7
0.200
 Why?
Neuroendocrine Cells
1
2021
11
0.200
 Why?
DNA Mutational Analysis
3
2018
217
0.200
 Why?
Cost-Benefit Analysis
2
2019
291
0.200
 Why?
Urethral Diseases
2
2013
7
0.200
 Why?
Adenoviridae
1
2020
58
0.190
 Why?
Follow-Up Studies
8
2019
2387
0.190
 Why?
Immunohistochemistry
4
2018
1089
0.190
 Why?
Radiosurgery
1
2022
122
0.190
 Why?
Reproducibility of Results
7
2018
1304
0.190
 Why?
Logistic Models
6
2021
995
0.190
 Why?
Radiography, Abdominal
1
2020
29
0.190
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2022
1056
0.190
 Why?
Reimbursement, Incentive
1
2020
14
0.190
 Why?
Genetic Vectors
1
2020
139
0.190
 Why?
Genetic Therapy
1
2020
121
0.180
 Why?
Randomized Controlled Trials as Topic
4
2023
596
0.180
 Why?
Ablation Techniques
1
2019
25
0.180
 Why?
Abdominal Pain
1
2020
77
0.180
 Why?
Mutation
5
2019
1501
0.180
 Why?
Venous Thromboembolism
1
2020
75
0.170
 Why?
Urinary Tract
1
2018
26
0.170
 Why?
Forecasting
1
2019
161
0.170
 Why?
Diagnosis, Differential
2
2020
1136
0.170
 Why?
Drug Resistance, Neoplasm
1
2020
309
0.170
 Why?
Lymphocytes
1
2019
168
0.170
 Why?
Neutrophils
1
2019
154
0.170
 Why?
RNA, Neoplasm
1
2018
54
0.170
 Why?
Patient-Centered Care
1
2020
134
0.170
 Why?
Genetic Heterogeneity
1
2018
22
0.160
 Why?
Predictive Value of Tests
6
2018
1048
0.160
 Why?
Erectile Dysfunction
2
2017
83
0.160
 Why?
Programmed Cell Death 1 Receptor
1
2018
40
0.160
 Why?
Obesity
2
2006
1202
0.160
 Why?
Retroperitoneal Neoplasms
1
2018
17
0.160
 Why?
Pain, Postoperative
2
2016
161
0.160
 Why?
Orchiectomy
1
2018
38
0.160
 Why?
Transurethral Resection of Prostate
1
2018
10
0.160
 Why?
Body Size
1
2017
30
0.160
 Why?
Electronic Health Records
1
2020
206
0.150
 Why?
Internship and Residency
2
2021
501
0.150
 Why?
Databases, Factual
2
2021
684
0.150
 Why?
Inguinal Canal
1
2017
11
0.150
 Why?
Urodynamics
2
2014
25
0.150
 Why?
Sarcosine
1
2017
1
0.150
 Why?
Physician-Patient Relations
2
2016
150
0.150
 Why?
Amino Acid Transport Systems
1
2017
6
0.150
 Why?
Quality Assurance, Health Care
1
2018
164
0.150
 Why?
Anticoagulants
1
2020
270
0.150
 Why?
Body Height
1
2017
76
0.150
 Why?
Carbon Radioisotopes
1
2017
54
0.150
 Why?
Safety
1
2017
92
0.150
 Why?
Transcriptome
2
2018
346
0.150
 Why?
Guidelines as Topic
1
2017
125
0.150
 Why?
Replantation
1
2016
13
0.150
 Why?
Disease-Free Survival
5
2016
485
0.150
 Why?
Scrotum
2
2015
34
0.150
 Why?
Nomograms
1
2016
6
0.140
 Why?
Laparotomy
1
2016
36
0.140
 Why?
Protons
1
2017
81
0.140
 Why?
Natural Orifice Endoscopic Surgery
1
2016
4
0.140
 Why?
Research Report
1
2016
16
0.140
 Why?
Urinary Retention
2
2007
7
0.140
 Why?
Patient Preference
1
2016
38
0.140
 Why?
Checklist
1
2016
36
0.140
 Why?
Kaplan-Meier Estimate
5
2017
514
0.140
 Why?
Time-to-Treatment
1
2016
74
0.140
 Why?
Ureteral Obstruction
1
2016
70
0.140
 Why?
Physicians
2
2016
247
0.140
 Why?
Preoperative Period
3
2021
59
0.130
 Why?
Genital Neoplasms, Male
1
2015
3
0.130
 Why?
Paget Disease, Extramammary
1
2015
5
0.130
 Why?
Social Networking
1
2015
15
0.130
 Why?
Sensitivity and Specificity
5
2018
923
0.130
 Why?
Recovery of Function
1
2016
222
0.130
 Why?
Feedback
1
2015
59
0.130
 Why?
Peer Group
1
2015
58
0.130
 Why?
Video Recording
1
2015
90
0.130
 Why?
Body Weight
1
2017
578
0.130
 Why?
Informed Consent
1
2015
92
0.130
 Why?
Lymph Nodes
1
2017
284
0.130
 Why?
Treatment Failure
2
2017
139
0.130
 Why?
Papilloma, Inverted
1
2014
1
0.130
 Why?
Radiopharmaceuticals
1
2016
238
0.130
 Why?
Proto-Oncogene Proteins B-raf
1
2015
90
0.120
 Why?
Equipment Design
3
2021
318
0.120
 Why?
Proto-Oncogene Proteins p21(ras)
1
2014
69
0.120
 Why?
Matched-Pair Analysis
1
2013
12
0.120
 Why?
Blood Loss, Surgical
5
2016
79
0.120
 Why?
Urinary Incontinence, Stress
1
2014
31
0.120
 Why?
Computer Simulation
1
2015
332
0.120
 Why?
Diffusion of Innovation
1
2013
50
0.120
 Why?
Body Mass Index
3
2020
713
0.120
 Why?
Technology Transfer
1
2013
1
0.120
 Why?
Mitomycin
1
2013
23
0.120
 Why?
Carcinoma, Papillary
1
2014
65
0.120
 Why?
General Surgery
1
2015
113
0.120
 Why?
Longitudinal Studies
2
2018
746
0.110
 Why?
Adenoma
1
2015
142
0.110
 Why?
Radiotherapy, Adjuvant
2
2018
66
0.110
 Why?
Kidney Diseases
1
2016
293
0.110
 Why?
Accreditation
1
2013
72
0.110
 Why?
Peripheral Nerves
1
2013
51
0.110
 Why?
Adjuvants, Immunologic
2
2023
61
0.110
 Why?
Education, Medical, Continuing
1
2013
80
0.110
 Why?
Severity of Illness Index
2
2014
1084
0.110
 Why?
Community Health Centers
1
2012
32
0.110
 Why?
Pathology, Clinical
1
2012
26
0.110
 Why?
Operating Rooms
1
2012
40
0.110
 Why?
Referral and Consultation
2
2012
307
0.100
 Why?
Algorithms
1
2015
697
0.100
 Why?
Combined Modality Therapy
3
2021
692
0.100
 Why?
Perioperative Care
1
2011
42
0.100
 Why?
Neoplasms
1
2021
1316
0.090
 Why?
Risk Factors
5
2017
3935
0.090
 Why?
Seminal Vesicles
2
2022
12
0.090
 Why?
Medicare
3
2020
241
0.090
 Why?
Multicenter Studies as Topic
2
2023
91
0.090
 Why?
Phantoms, Imaging
2
2020
126
0.090
 Why?
Skin Neoplasms
1
2015
532
0.090
 Why?
Proportional Hazards Models
3
2016
431
0.090
 Why?
Markov Chains
2
2019
34
0.080
 Why?
SEER Program
3
2014
91
0.080
 Why?
Carboplatin
2
2022
62
0.080
 Why?
Immunotherapy
1
2010
263
0.080
 Why?
Postoperative Care
2
2020
121
0.080
 Why?
Healthcare Disparities
1
2011
271
0.080
 Why?
Ureteroscopy
1
2007
13
0.080
 Why?
Sarcopenia
2
2021
83
0.080
 Why?
Automobiles
2
2017
16
0.080
 Why?
Diverticulum
1
2007
22
0.080
 Why?
Genetic Predisposition to Disease
3
2018
570
0.080
 Why?
Peritoneum
1
2007
12
0.080
 Why?
Chi-Square Distribution
3
2013
318
0.080
 Why?
Incidence
2
2021
1082
0.080
 Why?
Delphi Technique
2
2018
38
0.080
 Why?
Pandemics
2
2023
579
0.080
 Why?
Gene Amplification
2
2018
57
0.070
 Why?
Aftercare
2
2018
81
0.070
 Why?
Societies, Medical
2
2018
194
0.070
 Why?
Adrenalectomy
1
2006
33
0.070
 Why?
Cisplatin
2
2022
352
0.070
 Why?
Postoperative Hemorrhage
1
2006
53
0.070
 Why?
Promoter Regions, Genetic
2
2019
520
0.070
 Why?
Case-Control Studies
3
2014
1228
0.070
 Why?
Fibrin Tissue Adhesive
1
2005
12
0.070
 Why?
Tissue Adhesives
1
2005
15
0.070
 Why?
Hand
1
2005
57
0.070
 Why?
Sex Factors
2
2020
767
0.070
 Why?
Suture Techniques
1
2005
70
0.060
 Why?
Genomics
2
2018
310
0.060
 Why?
Diabetes Complications
1
2005
123
0.060
 Why?
Renal Insufficiency
1
2005
138
0.060
 Why?
Intestines
1
2006
204
0.060
 Why?
Glomerular Filtration Rate
2
2016
138
0.060
 Why?
Superior Mesenteric Artery Syndrome
1
2004
5
0.060
 Why?
Deoxycytidine
2
2014
28
0.060
 Why?
Hernia, Inguinal
1
2004
19
0.060
 Why?
Communication
2
2016
273
0.060
 Why?
Intraoperative Complications
1
2005
125
0.060
 Why?
Phenotype
2
2018
820
0.060
 Why?
High-Throughput Nucleotide Sequencing
2
2015
206
0.060
 Why?
Cell Line, Tumor
2
2018
1550
0.060
 Why?
Rectum
1
2023
51
0.060
 Why?
Papillomavirus Infections
2
2015
163
0.060
 Why?
Quality of Health Care
2
2015
222
0.060
 Why?
Perioperative Period
2
2013
25
0.060
 Why?
Ischemia
1
2004
177
0.060
 Why?
Liver Cirrhosis
1
2005
216
0.060
 Why?
Muscles
1
2022
114
0.050
 Why?
Polymorphism, Restriction Fragment Length
1
2002
44
0.050
 Why?
Odds Ratio
2
2014
604
0.050
 Why?
Gallium Isotopes
1
2021
2
0.050
 Why?
Gallium Radioisotopes
1
2021
8
0.050
 Why?
Edetic Acid
1
2021
15
0.050
 Why?
Receptors, Androgen
1
2002
49
0.050
 Why?
Androgen Antagonists
1
2021
15
0.050
 Why?
Radiotherapy, Intensity-Modulated
2
2013
170
0.050
 Why?
Geography
1
2021
81
0.050
 Why?
Accidents, Traffic
2
2017
117
0.050
 Why?
Public Health
1
2023
206
0.050
 Why?
Quarantine
1
2021
16
0.050
 Why?
Smoking
1
2005
556
0.050
 Why?
Internationality
1
2021
49
0.050
 Why?
Neoplasm Metastasis
2
2017
252
0.050
 Why?
Drug Dosage Calculations
1
2020
11
0.050
 Why?
Motion
1
2020
20
0.050
 Why?
Enoxaparin
1
2020
25
0.050
 Why?
Finite Element Analysis
1
2020
13
0.050
 Why?
Fellowships and Scholarships
1
2021
117
0.050
 Why?
Drug Monitoring
1
2020
85
0.050
 Why?
Pelvis
1
2020
76
0.050
 Why?
DNA-Directed RNA Polymerases
1
2019
25
0.040
 Why?
Abdomen
1
2020
83
0.040
 Why?
Heparin
1
2020
97
0.040
 Why?
Postoperative Period
1
2020
189
0.040
 Why?
Social Behavior
1
2019
85
0.040
 Why?
Urine
1
2018
35
0.040
 Why?
Cytodiagnosis
1
2018
44
0.040
 Why?
Diagnostic Errors
1
2018
74
0.040
 Why?
Single-Blind Method
1
2018
120
0.040
 Why?
DNA Copy Number Variations
1
2018
114
0.040
 Why?
Image Processing, Computer-Assisted
1
2019
256
0.040
 Why?
Quality-Adjusted Life Years
1
2018
70
0.040
 Why?
Sequence Analysis, RNA
1
2018
107
0.040
 Why?
Genome, Human
1
2018
131
0.040
 Why?
Delivery of Health Care, Integrated
1
2018
52
0.040
 Why?
Hospitalization
2
2017
705
0.040
 Why?
Health Services Accessibility
2
2012
432
0.040
 Why?
Random Allocation
1
2018
312
0.040
 Why?
Nephrons
1
2016
10
0.040
 Why?
Consensus
1
2018
157
0.040
 Why?
Tissue Distribution
1
2017
178
0.040
 Why?
Hospital Communication Systems
1
2016
6
0.040
 Why?
Failure to Thrive
1
2016
21
0.040
 Why?
Coitus
1
2016
20
0.040
 Why?
Anastomosis, Surgical
1
2016
72
0.040
 Why?
Salvage Therapy
1
2017
145
0.040
 Why?
Early Detection of Cancer
1
2018
162
0.040
 Why?
Dose-Response Relationship, Drug
1
2020
1476
0.040
 Why?
Creatinine
1
2016
169
0.040
 Why?
Radiometry
1
2017
124
0.030
 Why?
Cyclin-Dependent Kinase 4
1
2015
15
0.030
 Why?
Multiplex Polymerase Chain Reaction
1
2015
11
0.030
 Why?
Operative Time
1
2016
76
0.030
 Why?
Genes, erbB-1
1
2015
9
0.030
 Why?
Tape Recording
1
2015
8
0.030
 Why?
Molecular Imaging
1
2016
60
0.030
 Why?
Fever
1
2016
129
0.030
 Why?
Learning Curve
1
2015
22
0.030
 Why?
Groin
1
2015
16
0.030
 Why?
Tissue Array Analysis
1
2015
50
0.030
 Why?
Oncology Service, Hospital
1
2014
14
0.030
 Why?
Clinical Trials, Phase III as Topic
1
2015
48
0.030
 Why?
Child
2
2017
7341
0.030
 Why?
North America
1
2014
68
0.030
 Why?
Incontinence Pads
1
2014
2
0.030
 Why?
Europe
1
2014
102
0.030
 Why?
Vinblastine
1
2014
41
0.030
 Why?
In Situ Hybridization
1
2014
82
0.030
 Why?
Anxiety
1
2016
279
0.030
 Why?
Regression Analysis
1
2015
445
0.030
 Why?
Amino Acid Substitution
1
2014
105
0.030
 Why?
Personal Satisfaction
1
2014
90
0.030
 Why?
Gene Dosage
1
2014
91
0.030
 Why?
Kidney Failure, Chronic
1
2016
231
0.030
 Why?
Methotrexate
1
2014
73
0.030
 Why?
Gene Expression Regulation, Neoplastic
1
2018
866
0.030
 Why?
United States Department of Veterans Affairs
1
2015
315
0.030
 Why?
Papillomaviridae
1
2014
107
0.030
 Why?
Ultrasonography
1
2016
480
0.030
 Why?
Dysuria
1
2013
1
0.030
 Why?
Survivors
1
2014
137
0.030
 Why?
Anesthesiology
1
2014
46
0.030
 Why?
Intention to Treat Analysis
1
2013
28
0.030
 Why?
Valsalva Maneuver
1
2013
7
0.030
 Why?
Cluster Analysis
1
2014
249
0.030
 Why?
Prevalence
1
2016
1025
0.030
 Why?
Sequence Analysis, DNA
1
2014
273
0.030
 Why?
Diagnostic Tests, Routine
1
2013
31
0.030
 Why?
Stents
1
2016
375
0.030
 Why?
Gene Expression Profiling
1
2018
1138
0.030
 Why?
Doxorubicin
1
2014
259
0.030
 Why?
Health Services Research
1
2013
167
0.030
 Why?
Paclitaxel
1
2013
103
0.030
 Why?
Confidence Intervals
1
2013
167
0.030
 Why?
Antibiotics, Antineoplastic
1
2013
85
0.030
 Why?
Neutropenia
1
2013
120
0.030
 Why?
Angiomyolipoma
1
2012
10
0.030
 Why?
Thrombocytopenia
1
2013
99
0.030
 Why?
Survival Analysis
1
2014
735
0.030
 Why?
Tertiary Care Centers
1
2012
83
0.030
 Why?
Unnecessary Procedures
1
2012
25
0.030
 Why?
Neoplasm, Residual
1
2013
166
0.030
 Why?
Attitude of Health Personnel
1
2015
397
0.030
 Why?
Neoplasms, Multiple Primary
1
2012
45
0.030
 Why?
Biopsy, Fine-Needle
1
2012
116
0.030
 Why?
Pilot Projects
1
2014
808
0.020
 Why?
Patient Positioning
1
2011
35
0.020
 Why?
Urination Disorders
1
2010
19
0.020
 Why?
Disease Management
1
2012
184
0.020
 Why?
Organ Size
1
2010
237
0.020
 Why?
Comorbidity
1
2012
663
0.020
 Why?
Socioeconomic Factors
1
2011
642
0.020
 Why?
Health Status Disparities
1
2011
219
0.020
 Why?
Intraoperative Period
1
2007
51
0.020
 Why?
Costs and Cost Analysis
1
2006
109
0.020
 Why?
Erythrocyte Transfusion
1
2006
74
0.020
 Why?
Decision Trees
1
2005
26
0.020
 Why?
Hypertension, Portal
1
2005
17
0.020
 Why?
Portal System
1
2005
17
0.020
 Why?
Collateral Circulation
1
2005
41
0.020
 Why?
Reoperation
1
2006
454
0.020
 Why?
Short Bowel Syndrome
1
2004
15
0.020
 Why?
Blood Transfusion
1
2005
138
0.010
 Why?
Necrosis
1
2004
208
0.010
 Why?
Adolescent
1
2015
6897
0.010
 Why?
Liver Transplantation
1
2005
160
0.010
 Why?
Young Adult
1
2012
4318
0.010
 Why?
Genetic Markers
1
2002
117
0.010
 Why?
Statistics, Nonparametric
1
2002
232
0.010
 Why?
Base Sequence
1
2002
719
0.010
 Why?
Polymerase Chain Reaction
1
2002
531
0.010
 Why?
Molecular Sequence Data
1
2002
980
0.010
 Why?
Montgomery's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (424) concept(s)
_
Co-Authors Expand Description
See all (1) people
_
Similar People Expand Description
See all (23) people
_
Same Department Expand Description
Search Department